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Abstract. 
 
Dividing populations of stratified and simple 
epithelial tissues express keratins 5 and 14, and keratins 
8 and 18, respectively. It has been suggested that these 
keratins form a mechanical framework important to 
cellular integrity, since their absence gives rise to a blis-
tering skin disorder in neonatal epidermis, and hemor-
rhaging within the embryonic liver. An unresolved fun-
damental issue is whether different keratins perform 
unique functions in epithelia. We now address this 
question using transgenic technology to express a K16-
14 hybrid epidermal keratin transgene and a K18 sim-
ple epithelial keratin transgene in the epidermis of mice 
null for K14. Under conditions where the hybrid epi-
dermal keratin restored a wild-type phenotype to new-
born epidermis, K18 partially but not fully rescued. The 
explanation does not appear to reside in an inability of 
K18 to form 10-nm filaments with K5, which it does in 
 
vitro
 
 
 
and in vivo. Rather, it appears that the keratin 
network formed between K5 and K18 is deficient in 
withstanding mechanical stress, leading to perturba-
tions in the keratin network in regions of the skin that 
are subjected either to natural or to mechanically in-
duced trauma. Taken together, these findings suggest 
that the loss of a type I epidermal keratin cannot be 
fully compensated by its counterpart of simple epithe-
lial cells, and that in vivo
 
,
 
 all keratins are not equiva-
lent.
Key words: keratins • intermediate filaments • func-
 
tional redundancy • epidermis • epithelia
 
K
 
eratins
 
 belong to the superfamily of intermediate
filament (IF)
 
1
 
 proteins, which have the remark-
able capacity to assemble into 10-nm filaments in
vitro, in the absence of auxiliary proteins or factors (for re-
view see Fuchs and Weber, 1994). They are composed of
two sequence types, both of which share a common,
largely 
 
a
 
-helical secondary structure, capable of forming
coiled-coil heterodimers, which then further assemble to
form obligatory heteropolymers. Type I keratins include
K9-K20 and type II keratins encompass K1-K8 (Moll et
al., 1982). While most combinations of type I and type II
keratins can copolymerize in vitro (Franke et al., 1983),
keratins are often coexpressed as specific pairs in vivo,
where they are largely restricted to epithelial tissues (Sun
et al., 1984).
The innermost, mitotically active (basal) layer of many
stratified epithelial tissues, including the epidermis, cor-
nea, and tongue, express the type II keratin K5 and the
type I keratin K14 (Fuchs and Green, 1980; Moll et al.,
1982; Nelson and Sun, 1983; Byrne et al., 1994). A second
natural partner for K5 is K15, which is more abundantly
expressed in internal stratified squamous epithelia, such as
esophagus (Moll et al., 1982; Leube et al., 1988; Lloyd et
al., 1995). As keratinocytes of stratified tissues withdraw
from the cell cycle and commit to differentiate, they often
downregulate transcription of K5/K14 (K5/K15); concomi-
tantly, as the differentiating cells move into the upper lay-
ers, they induce one of five to six different pairs of kera-
tin genes depending upon the particular stratified tissue
(Fuchs and Green, 1980; Moll et al., 1982). In contrast to
these elaborate patterns in stratified tissues, simple epithe-
lia express K8 and K18, and only under certain circum-
stances do they express additional keratins K7 and K19
(Moll et al., 1982; Wu et al., 1982).
One role that has been ascribed to the various keratin
filament networks of stratified squamous epithelia is to
impart mechanical integrity to cells, without which, the
cells become fragile and prone to rupturing. This function
was initially proposed on the basis of transgenic mice engi-
neered to express a dominant-negative K14 mutant (Vas-
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Abbreviations used in this paper
 
: BS3, bis(sulfosuccinimidyl)suberate;
EBS, epidermis bullosa simplex; IF, intermediate filament.
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sar et al., 1991), and it has been documented by K14 null
mutations identified in both mice (Lloyd et al., 1995) and
humans (Chan et al., 1994; Rugg et al., 1994). In all of
these cases, the skin displays features of epidermolysis
bullosa simplex (EBS), a blistering disorder typified by
basal epidermal cell rupturing upon mild mechanical stress
(Fitzpatrick et al., 1993; Fuchs and Cleveland, 1998). Simi-
larly, mice expressing a mutant version of the K10 gene,
normally expressed in differentiating epidermal cells, ex-
hibit features of epidermolytic hyperkeratosis (EH), a dis-
order analogous to EBS but involving suprabasal rather
than basal cell degeneration (Fuchs et al., 1992; Porter et
al., 1996). In humans, EBS and EH are generally autoso-
mal dominant skin disorders, and correlate with the ap-
pearance of clumps or aggregates of keratin filaments in
the cell cytoplasm (Anton-Lamprecht, 1994).
It is now well established that these mechanically in-
duced blistering disorders of the epidermis involve muta-
tions in keratins (Bonifas et al., 1991; Coulombe et al.,
1991; Cheng et al., 1992; Chipev et al., 1992; Lane et al.,
1992; Rothnagel et al., 1992). Recently, a number of other
keratin disorders have been identified genetically, and
they involve additional stratified epithelial tissues, includ-
ing cornea, esophagus, and hair; they are characterized by
cell degeneration and mechanical fragility (for review see
Fuchs and Cleveland, 1998). Where tested, the severity of
these diseases seems to correlate with the degree to which
the keratin mutants perturb IF assembly in vitro (Letai et
al., 1993).
Human disorders involving simple epithelial keratins
have not yet been established, although a K18 mutation
was reported recently in a patient with cryptogenic cirrho-
sis, a liver disorder (Ku and Omary, 1994; Ku et al., 1997),
and transgenic mice expressing a mutant K18 develop
chronic hepatitis (Ku et al., 1995, 1996). Simple epithelial
keratins may also function to maintain hepatocyte integ-
rity as evidenced by (
 
a
 
) the death of some K8 null mouse
embryos resulting from hemorrhaging of the liver at the
time of vascularization (Baribault et al., 1993); (
 
b
 
) the liver
necrosis in adult K8 mice when subjected to hepatectomy
(Loranger et al., 1997); and (
 
c
 
) the signs of hepatitis seen
in adult K18 null mice, which also display K8 aggregates in
their hepatocytes (Magin et al., 1998). Taken together,
these findings suggest a special importance of simple epi-
thelial keratins in the liver. A role for K8/K18 in intestinal
epithelia has also surfaced in that one strain of K8 null
mice displays marked colorectal hyperplasia and inflam-
mation (Baribault et al., 1994). Whether simple epithelial
keratins function to impart mechanical integrity, however,
is considerably less clear than it is for stratified epithelial
keratins.
If keratins have comparable functions in different tis-
sues, then what is the functional significance of the multi-
plicity of keratin sequences? Is it that keratin genes have
simply duplicated and diverged over evolution, but func-
tionally the gene products are redundant? Or, did differ-
ent keratin genes evolve to suit the particular functional
needs of the tissues in which they are expressed? To begin
to explore the answer to this fundamental issue of keratin
biology, we have used transgenic technology to replace
K14 with K18 gene expression in K14 null mice. We show
that while K18 can coassemble with K5 into a keratin fila-
ment network in vivo and in vitro, the keratin network is
unable to withstand mechanical trauma, giving rise to nat-
ural skin blistering in the paws and to mechanically in-
duced blistering in the back. Our findings suggest that ker-
atins within a single family type have specially tailored
properties and are not functionally redundant. They fur-
ther support the notion that keratins have evolved to suit
the particular structural and functional needs of different
epithelial tissues.
 
Materials and Methods
 
Generation of Transgenes
 
A K14 transgene was generated using 2,100 bp of the human K14 pro-
moter to drive expression of a hybrid human K16-14 cDNA. The hybrid
K16-14 cDNA was assembled from human K14 cDNA and human K16
cDNA. A conserved SphI site was used to engineer the hybrid cDNA, re-
sulting in an encoded 49-kD protein containing 368 amino acid (a.a.) resi-
dues of human K16 and 105 a.a. of human K14 (Wawersik et al., 1997). A
human K18 transgene was generated using 2,100 bp of human K14 pro-
moter to drive expression of a full-length human K18 cDNA, provided by
Dr. R. Oshima (Burnham Institute, La Jolla, CA) (Oshima et al., 1986).
The 1,425-bp K18 cDNA was placed in a mammalian epidermal expres-
sion vector (Vassar et al., 1989), modified to contain a globin intron se-
quence in the 5
 
9 
 
untranslated region.
 
Engineering the K14 Null Mice Replaced by Either the 
K14 or K18 Transgene
 
Genetically engineered transgenes were microinjected into fertilized, sin-
gle cell embryos (CD-1 for K18; B6C3 F2 for K16-14), and after culturing
the embryos to the two cell stage, they were transferred to the oviducts of
pseudopregnant female mice (Vassar et al., 1991; Paladini and Coulombe,
1998). 3 wk after birth, ear or tail samples were taken for DNA analysis.
Presence of the transgene was determined by PCR or Southern blotting of
these DNAs. Mice expressing the transgenes were then bred to mice that
were null for the K14 gene (Lloyd et al., 1995). Genotyping was deter-
mined by Southern blot analysis and/or PCR using the conditions and
probes described (Lloyd et al., 1995; Paladini and Coulombe, 1998).
 
Immunoblot Analyses
 
Intermediate filaments were isolated from skin samples as described (Wu
et al., 1982), and keratins were solubilized in a solution of 8 M urea and
10% 
 
b
 
-mercaptoethanol. Water-soluble proteins were concentrated at
4
 
8
 
C with a Microcon 10 concentrator (Amicon W.R. Grace & Co., Bev-
erly, MA). After electrophoretic transfer of SDS-PAGE–resolved IF pro-
teins to nitrocellulose, blots were pre-incubated overnight in 1% gelatin
(Sigma Chemical Co., St. Louis, MO), 20 mM Tris HCl, pH 7.6, 150 mM
NaCl, and 0.1% Tween-20, followed by incubation with primary antibody
for 1 h and washing three times for 10 min each in PBS, 0.5% Tween-20.
After this procedure, blots were then developed using either a HRP-con-
jugated secondary antibody and chemiluminescence ECL (Amersham
Corp., Arlington Heights, IL) or an alkaline phosphatase–conjugated sec-
ondary antibody and color development (Bio-Rad Laboratories, Her-
cules, CA). Primary antibodies included: (
 
a
 
) mouse CY-90 anti-K18 mAb
(Sigma Chemical Co.), (
 
b
 
) rabbit polyclonal anti-K14 COOH-terminal
peptide antibody (Stoler et al., 1988), or (
 
c
 
) guinea pig polyclonal anti-K5
COOH-terminal peptide antibody (Lersch et al., 1989). For successive in-
cubations after ECL development, blots were stripped at 70
 
8
 
C in 62.5 mM
Tris HCl, pH 7.6, 2% SDS, 0.7% 
 
b
 
-mercaptoethanol. To quantitate sig-
nals, blots were scanned into a densitometer (Molecular Dynamics,
Sunnyvale, CA), and protein levels were determined with ImageQuant
software (Molecular Dynamics).
 
Immunohistochemistry
 
Animals were killed at 1, 2, or 5 d of age, or as adults, and skin was frozen
in isopentane, sectioned (8 
 
m
 
m), and then processed for immunofluores-
cence immunohistochemistry. Antisera were used at the following dilu-
tions: anti-K14, 1:200 (Stoler et al., 1988); anti-K18, 1:200 (Sigma Chemi- 
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cal Co.); anti-K6, 1:200 (gift of D. Roop, Baylor College of Medicine,
Houston, TX); anti-K5, 1:200 (Lersch et al., 1989). All secondary antibod-
ies, conjugated to either FITC or Texas red were obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA).
 
Ultrastructural Analyses
 
Tissues were obtained from the skin of duplicate K14 null, K14 wild-type,
K14 null/K16-14 transgenic, K14 null/K18 transgenic, and K14 wild-type/
K18 transgenic animals, killed at 2–3 d of age. For conventional transmis-
sion electron microscopy, tissues were immediately fixed in 2.5% glutaral-
dehyde and 4% formaldehyde, pH 7.3, for 24 h, followed by postfixation
with 1% osmium tetroxide for 1 h. After en bloc staining and dehydration
with ethanol, the samples were embedded with LX-112 medium (Ladd
Research Industries, Burlington, Vermont). All tissues had been properly
oriented to ensure that the entire thickness of epidermis or mucous mem-
brane would be sectioned perpendicular to the normal tissue plane. Semi-
thin sections were stained with toluidine blue. Ultrathin sections of 80 nm
were cut with a diamond knife, mounted on uncoated grids, stained with
uranyl acetate and lead citrate, and then observed with a JEOL-CXII
electron microscope (JEOL USA, Inc., Peabody, MA) operated at 60 kv.
For immunoelectron microscopy, the methods of Warhol et al. (1985)
and Coulombe et al. (1989) were used with some modifications. The tis-
sues were (
 
a
 
) fixed with 2% PFA, 0.1% glutaraldehyde in PBS for 6 h, (
 
b
 
)
dehydrated with ethanol and embedded with Lowicryl K4M medium
(Ladd Research Industries) at 
 
2
 
20
 
8
 
C, and then (
 
c
 
) polymerized with UV
light for 7 d at 
 
2
 
20
 
8
 
C. Ultrathin sections were mounted on Formvar/car-
bon-coated nickel grids. All sections were first incubated overnight with
polyclonal rabbit antisera monospecific for either K14 (1:200), K5 (1:100),
or K18 (1:100), followed by a 45-min incubation with a secondary anti-
body, 20-nm gold–conjugated goat anti–rabbit IgG. All grids were then
briefly stained with uranyl acetate and lead citrate, and then examined
with a JEOL-CXII electron microscope at 60 kV.
 
Filament Assembly Studies
 
The assembly properties of K5-K18 and K5-K14 were compared using as-
says previously described (Coulombe and Fuchs, 1990; Wawersik et al.,
1997). Plasmids pET-K5 and pET-K14 (Coulombe and Fuchs, 1990) and
pET-K18 (Ku et al., 1997) were transformed into 
 
Escherichia coli
 
 strain
BL21 (DE3) to generate mg amounts of the corresponding recombinant
human keratins. Purified type I and type II keratins were mixed in a 
 
z
 
45:
55 molar ratio at a final concentration of 500 
 
m
 
g/ml in 6 M urea buffer, in-
cubated for 1 h at room temperature, and then fractionated by anion ex-
change chromatography on a Pharmacia Mono Q column (Pharmacia
Biotech, Inc., Piscataway, NJ). Collected fractions were analyzed by SDS-
PAGE and those containing type I–type II heterotypic complexes were
pooled.
To assay for tetramer formation, the K5-K18 and K5-K14 samples were
dialyzed against 25 mM sodium phosphate and 10 mM 
 
b
 
-ME, containing
6 M or 8 M urea at pH 7.4, to remove Tris ions. Protein concentration was
adjusted to 200 
 
m
 
g/ml, and chemical cross-linking was performed by add-
ing BS3 (Bis-[sulfosuccinimidyl] suberate; Pierce Chemical Co., Rockford,
IL) to a final concentration of 5 mM for 1 h at room temperature. Cross-
linked products (6 
 
m
 
g proteins) were resolved on a 4–16% gradient SDS-
PAGE, and stained with Coomassie blue.
To assay for polymerization into filaments, the K5-K18 and K5-K14
samples (200 
 
m
 
g/ml) were serially dialyzed against the following buffers at
room temperature: (
 
a
 
) 9 M urea, 25 mM Tris-HCl, 10 mM 
 
b
 
-ME, pH 8.1;
(
 
b
 
) 4 M urea, 25 mM Tris-HCl, 5 mM 
 
b
 
-ME, pH 7.4; and (
 
c
 
) 5 mM Tris-
HCl, 5 mM 
 
b
 
-ME, pH 7.4. Assemblies were examined by negative staining
(1% aqueous uranyl acetate) using a Zeiss electron microscope (Carl
Zeiss Inc., Thornwood, NY). Polymerization efficiency was determined by
subjecting final assemblies (40 
 
m
 
l aliquots, 
 
z
 
8 
 
m
 
g proteins) to centrifuga-
tion at 100,000 
 
g
 
 for 60 min at 4
 
8
 
C (Airfuge; Beckman Coulter, Inc., Ful-
lerton, CA). Supernatant and pellet fractions were analyzed by SDS-
PAGE and Coomassie blue staining.
 
Results
 
A K16-14 Hybrid Transgene Rescues Blistering in K14 
Null Mice
 
The hallmark of K14 null mice is that they display marked
blistering over their paws shortly after birth (Lloyd et al.,
1995). Our first aim was to determine if we could rescue
this phenotype by expressing a K14-like transgene using
2,100 bp of the human K14 promoter (Vassar et al., 1989).
Fig. 1 shows the rescue vector, which contains a significant
portion of human K16 coding sequence to facilitate its dis-
tinction by size from endogenous K14, and to facilitate
quantitation of transgene levels relative to endogenous
K14 levels. The hybrid retains the COOH-terminal epi-
tope of K14, to which a peptide-specific antibody exists
(Stoler et al., 1988). Transgenic mice were generated by
standard procedures, and confirmed by Southern blot
analysis (Paladini and Coulombe, 1998). Mice from two
K16-14–expressing lines were generated. Expression of
the hybrid K16-14 at 
 
#
 
75% relative to endogenous K14
levels does not cause any detectable alteration in the skin
of transgenic mice (Paladini and Coulombe, 1998).
To quantitate the levels of transgene expression for the
present study, we isolated the IF proteins from tail skins
and conducted SDS-PAGE, followed by immunoblot
analysis to detect the transgene product and the endoge-
nous K14, both of which share identical COOH-terminal
sequences (Fig. 1). The antibody detected an additional
49-kD band in the transgene skin extract (Fig. 1 
 
A
 
) that
was not present in the wild-type skin extract (Fig. 1 
 
B
 
).
The 52-kD band corresponding to endogenous K14 was
detected in both transgenic and wild-type skin extracts.
Densitometry scanning revealed that in mice heterozygous
for the K16-K14 transgene locus, the transgene product
was present at 17% 
 
6
 
 3% the level of K14 in the lower ex-
pressing line (shown) and at 
 
z
 
50% the level of K14 in the
higher expressing line (data not shown). These mice were
then bred to the K14 null animals to generate mice with a
basal epidermal layer null for K14 and positive for the
K16-14 transgene. Animals were genotyped by Southern
blot analysis.
Figure 1. Expression of K16-K14 in transgenic mice. (A) A sche-
matic of the replacement vector, showing 2,100 bp of the human
K14 promoter (hK14), followed by the 59 intron and 59 untrans-
lated sequence from the rabbit b-globin gene (b int), followed by
a K16-14 hybrid transgene followed by the K14 39 untranslated
sequence (see Allen et al., 1996 for expression vector). The dot-
ted vertical lines demarcate the relative portions of K16 versus
K14 coding sequences used (see Paladini and Coulombe, 1998).
(B) IF proteins were isolated from the skins of K16-K14 trans-
genic (lane 1) and control (lane 2) neonatal mice. Proteins were
then subjected to SDS-PAGE. Gels were subjected to immuno-
blot analysis using an antibody against the COOH terminus of
K14, also present in the 49-kD transgene product. Relative
amounts of transgenic versus wild-type K14 were determined by
densitometry scanning. Sample shown is from the low expressing
K16-14 transgenic mouse. 
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Mice from both K16-K14 transgenic/K14 null lines ap-
peared normal at birth and exhibited no blistering over
their body or paws. Animals remained blister-free as they
became adults. A more detailed analysis of these mice will
be described elsewhere. Histological analysis revealed no
signs of epidermal abnormalities, even in the palmar re-
gion of the paws, subjected naturally to substantial me-
chanical stress (Fig. 2 
 
A
 
). In palmar areas and elsewhere
throughout the K16-14 replacement skin, an ordered pro-
gram of differentiation was observed, with mitotically ac-
tive basal cells in the inner layer, spinous cells, granular
layer cells, and stratum corneum (Fig. 2, 
 
A
 
 and 
 
B
 
). This
was in marked contrast to K14 null skin, which displayed
gross blistering within 2 d of birth (Lloyd et al., 1995). Blis-
tering was very bad in the palmar regions of K14 null skin
where rete ridges are typically seen (not shown), and was
prominent even in areas with hair follicles (Fig. 2 
 
C
 
). At
the histological level, clear cytoplasm and intraepidermal
rupturing was seen within the basal layer (Fig. 2 
 
C
 
; Lloyd
et al., 1995). These findings demonstrate that in the pres-
ence of K16-14, the skin blistering phenotype typical of
neonatal K14 null mice was rescued.
To investigate whether there might be more subtle aber-
rations in the basal cell cytoarchitecture of K16-14 trans-
genic/K14 null replacement epidermis, we examined the
skin by electron microscopy. As shown in Fig. 3, replace-
ment paw skin basal cells showed abundant keratin fila-
ments (
 
A
 
), not seen in the K14 null cells (
 
B
 
). These filaments
associated with desmosomes and with hemidesmosomes,
as expected for wild-type keratin networks. Furthermore,
no signs of microscopic blistering were visible in these
samples. Overall, the macroscopic and microscopic ap-
pearance of the K16-14 skin was similar to that of K14 
 
6
 
or wild-type skin (Fig. 3 
 
C
 
).
 
Generating K18 Transgenic Mice and Quantitating the 
Level of Transgene Expression
 
To test the functional significance of the multiplicity of
keratin sequences, we next focused our attention on re-
placing the major epidermal type I keratin K14 with the
major simple epithelial type I keratin K18. These keratins
share only 48% sequence identity at the amino acid level,
and are the most distantly related among the type I ker-
atins. Fig. 4 illustrates the K14 promoter–K18 transgene
that was injected into fertilized mouse eggs to engineer
transgenic mice. In this case, we did not use any epitope
tags or manipulations of K18, which might complicate in-
terpretation of the rescue. Mice that test positive by
Southern blot analysis for the K14 promoter–driven K18
transgene were then bred to the F1 generation.
We first demonstrated that the 
 
a
 
K18 mAb used for our
studies did not cross-react with endogenous skin keratins.
As judged by indirect immunofluorescence of frozen tis-
sue from normal mice, no 
 
a
 
K18 staining was observed
(Fig. 4, 
 
A
 
 and 
 
B
 
). In contrast to control skin, tissue from
Figure 2. The cytolysis in the basal layer of K14
null epidermis is missing when these cells express
the K16-14 transgene. Semithin (0.75 mm) sec-
tions of neonatal paw skin biopsies from (A and
B) K14 null/K16-14 transgenic and (C) K14 null
mice. Skins were embedded in Epon and stained
with Toluidine blue. Section in A is from central
paw, showing that even in areas rich in rete
ridges, the K16-14–expressing, K14 null paw skin
appears indistinguishable from wild type. Basal
cells from the equivalent region of K14 null skin were fully cytolyzed, leading to complete separation of the upper epidermis (not
shown). Areas of paw skin from areas where hair follicles were still sparse, but where rete ridges were no longer present were still nor-
mal in the replacement skin (B), but partially blistered in the K14 null skin (C). Bar, 30 mm.
Figure 3. K14 null mice expressing
the K16-14 transgene have basal
epidermal cells that are rich in kera-
tin filament bundles and similar to
wild-type basal cells. Paw skin sam-
ples were taken from neonatal age-
matched animals that were either
K16-14 transgenic/K14 null, K14
null, or wild type. Skins were pro-
cessed for electron microscopy. (A)
Basal cell of K16-14 paw skin in
area of rete ridge formation. Basal
cells show bundles of keratin fila-
ments (Kf) in cytoplasm. No signs
of microblistering or basal cell cy-
tolysis were evident here, or else-
where throughout the skin. (B)
Basal layer of K14 null mouse skin. Note that keratin filament bundles are largely absent. Note also the presence of basal cell cytol-
ysis (asterisks). (C) Basal layer from wild-type mouse skin. Note presence of bundles of keratin filaments (Kf). Nu, nucleus; BL,
basal lamina; Mi, mitochondria; De, desmosome; Hd, hemidesmosome. Bar, 0.5 mm. 
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several K18 transgenic mouse lines displayed strong stain-
ing with 
 
a
 
K18, and this paralleled the staining pattern ob-
served with 
 
a
 
K14 (example shown in Fig. 4, 
 
C
 
 and 
 
D
 
, re-
spectively). Both 
 
a
 
K18 and 
 
a
 
K14 staining often extended
beyond the basal and into the suprabasal layers, reflective
of the ability of epidermal keratins to persist long after
their synthesis (Fuchs and Green, 1980; Roop et al., 1987).
Overall, these data demonstrated that K18 was faithfully
expressed in a pattern identical to that of K14.
To examine the behavior of K18 protein in basal epi-
dermal keratinocytes, we conducted two-dimensional gel
electrophoresis on keratins extracted from K18 transgenic
mouse skin. Coomassie blue staining revealed two to three
spots, not present in control skin samples, that migrated at
the molecular size (
 
z
 
44 kD) and pKi (5.5) expected for
K18 (Fig. 5 
 
A
 
). The identity of these spots was confirmed
by 
 
aK18 immunoblot analysis (Fig. 5 B). The size and pKi
of K18 in transgenic mouse epidermis was comparable to
that observed in simple epithelia (Moll et al., 1982), sug-
gesting that its expression in epidermis did not result in
any substantial processing or modifications of the protein.
Heterozygous K18 positive mice were mated with K14
heterozygous mice, and eventually bred further to produce
K18 positive/K14 null animals. As shown in Fig. 5 C, the
keratin extracts from the skins of these animals lacked the
K14 spots, but still contained K18 spots of approximately
the same isoelectric points, size, and levels as those seen in
the transgenic skin extracts.
To assess the levels of K18 transgene expression relative
to endogenous K14, we had to modify the approach we
had used for the K16-14 protein (see Fig. 1 B), since K18
and K14 did not share a common antibody epitope. In the
first approach, we subjected the Coomassie-stained, two-
dimensional gels of transgenic samples to densitometry
scanning, and compared directly the relative density of the
K18 versus K14 spots. Using this method, transgene ex-
pression ranged from 5% to 45% of the wild-type K14 lev-
els depending upon the mouse. The example shown in Fig.
5 A is from the transgenic line used for this and subse-
quent studies, which on a background of two K14 alleles is
Figure 4. K18 replacement vector and transgene expression in
mouse skin. (Top) Schematic depicting the K18 replacement
vector. The backbone of the vector is as described in Fig. 1.
The full-length human K18 cDNA (Oshima et al., 1986) was
introduced into the BamHI site of the vector. Frozen, methanol-
fixed sections of back skins (10 mm) of neonatal K18 transgenic
mice (tg) on a wild-type K14 background were subjected to
double-immunofluorescence microscopy using antibodies against
K18 (FITC-conjugated secondary) and K14 (Texas red–conju-
gated secondary), respectively (see Materials and Methods). A
and B, wild-type skin; C and D, K18 transgenic skin. Bar, 40 mm.
Figure 5. Polyacrylamide gel analysis of IF proteins. IF proteins
were extracted from the skins of neonatal transgenic mice ex-
pressing the K18 transgene on a wild-type (A and B) or K14 null
(C) background. A–C, duplicate gels were either stained with
Coomassie blue (A and C) or transferred to nitrocellulose paper
for immunoblot analysis with K18 (B) or K14 (not shown) anti-
bodies. Shown are the type I keratins. K10 is far more abundant
than K14 (spot below K10 in A). Note that the K14 spot, con-
firmed by immunoblot analysis, is missing in C. (Note: we do not
know the identity of the very acidic spot in C; it does not migrate
at a pKi or size known to keratins, and it was not consistently ob-
tained in our 0.6 M KCl–insoluble extracts.) (D and E) Duplicate
samples of IF proteins from wild-type (wt) and K18 transgenic
(Tg) mouse skins and dilutions of purified recombinant human
K18 or K14 were subjected to one-dimensional gel electrophore-
sis and immunoblot analysis using aK18 or aK14 antibodies.
Loadings were: wt, 4 mg extract; Tg, 2 mg and 4 mg extract, respec-
tively. Recombinant protein loadings are as indicated in nano-
grams.The Journal of Cell Biology, Volume 143, 1998 492
35% 6 5%. In the second approach, we used one dimen-
sional PAGE of IF extracts from this line, followed by im-
munoblot analysis with antibodies against K18 and K14,
respectively. In this case, we used varying dilutions of puri-
fied recombinant human K18 and K14 as standards, so
that we could determine the approximate number of nano-
grams of K18 and K14 in the transgenic skin extracts (Fig.
5, D and E). Two different anti-K18 antibodies, multiple
gels, and multiple exposures were used in the quantita-
tion, which again provided an estimate that the sample
contained K18 at levels that were 35% 6 5% the levels
of K14.
To further explore the K18 protein on a K14 null back-
ground, we conducted immunoblot analysis, this time us-
ing one-dimensional gel electrophoresis that enabled us to
examine and compare more samples. As shown in Fig. 6,
the immunoblot data verified the presence of K18 and the
absence of K14 in the skin of some offspring from het-
erozygous matings. Moreover, the K18 isolated from these
skins was found in the insoluble cytoskeletal fraction,
along with the other keratins, consistent with the notion
that it existed as part of the keratin network. The levels of
K18 were at least comparable to, if not higher than, those
in the K18 transgenic mice.
Immunofluorescence of skin sections from the K18
transgenic/K14 null mice revealed a pattern of aK18 anti-
body staining that was similar to what we saw in the trans-
genic mouse skin; in this case, however, K14 was absent
(Fig. 7, A and B, respectively). This K18 was strictly due to
transgene expression and not to induction of endogenous
Figure 6. Immunoblot analyses of skin IF proteins from wild-
type, K14 null, K18 transgenic, and K18 rescue mice. Triton X-100–
insoluble and –soluble protein extracts were prepared from back
skins of 1–2-d-old mice, resolved by electrophoresis through 10%
SDS–polyacrylamide gels (Wu et al., 1982) and transferred to ni-
trocellulose paper. The blot was then sequentially hybridized
with antibodies against K18, K14, and K5. After each hybridiza-
tion, bound antibody was visualized by chemiluminescence (Am-
ersham Corporation), and the blot was then stripped to remove
the bound antibody before proceeding with the next antibody.
Extracts are as indicated: WT, wild-type; KO, K14 null; K18 tg,
K18 transgenic; and K18 res, two different lines of K18 rescue.
Note that both transgene protein and endogenous keratins reside
in the insoluble fraction. Molecular mass standards at right in kD.
Figure 7. K18 expression is still maintained and does not induce
K6 when K18 transgenic mice are bred onto a K14 null back-
ground. Neonatal back skins and paw skins of control (not
shown) and K181/K14 null mice (K18 res) were frozen and
methanol-fixed, sectioned (10 mm), and then stained with anti-
bodies against the keratins indicated. (Note: depending upon the
fixation/processing conditions, antibody staining of K18 some-
times extended into the suprabasal layers. This happened incon-
sistently in control as well as transgenic skin, and in all cases, was
always paralleled by an identical staining pattern with aK5.) Note
the wild-type staining pattern of aK6 in the outer root sheath of
hair follicles; suprabasal epidermal induction of K6, a typical
marker of hyperproliferative disorders did not occur in K18 res-
cue skin. Bar, 40 mm.Hutton et al. K14/K18 Replacement in Knockout Mice 493
K18, since no aK18 staining was detected in K14 null skin
(not shown). The pattern of expression of K18 paralleled
that of K5, the normal partner of K14 (Fig. 7, C and D).
The exchange that we genetically engineered between K18
and K14 did not result in the induction within the basal
layer of K6 and K16, the keratin pair known to be ex-
pressed normally in the outer root sheath of the hair folli-
cle (see Fig. 7 E) and induced upon wound healing and a
variety of hyperproliferative disorders in the skin (Sun et
al., 1984; Mansbridge and Knapp, 1987; Paladini et al.,
1996). Thus, the genetic exchange appeared to occur in the
absence of other alterations in keratin expression.
Expression of the K18 Transgene on a K14 Null 
Background Restores Back Skin Morphology, but Not 
Paw Blistering
When bred on either a K14 wild-type background or a K14
1/2 heterozygous background, our K18 transgenic mice
appeared phenotypically and histologically indistinguish-
able from the wild type. These animals lived to adulthood,
showed no loss in viability, and developed no signs of ab-
errations in their skin or hair coat. This was important,
since there are a number of cases where ectopic expression
of a keratin can induce phenotypic changes (Powell and
Rogers, 1990; Blessing et al., 1993; Paladini and Cou-
lombe, 1998).
Even when bred to produce K181/K14 null mice, cer-
tain features of the animals were typical of wild-type mice.
Most notably, the back skin morphology of K181/K14 null
mice was similar to that of wild-type back skin, exhibiting
no signs of basal cell cytolysis or of alterations in terminal
differentiation (Fig. 8 A). Within 2–3 d after birth, how-
ever, the paws of these mice began to display signs of EBS,
including signs of basal cell degeneration within the cyto-
plasm of basal cells (Fig. 8 B). In most regions of the ven-
tral paw, basal epidermal cells showed gross signs of cytol-
ysis (Fig. 8 C), and often the basal layer was completely
degenerated, leading to detachment of the epidermis, and
only remnants of basal cells attached to the blister floor
(Fig. 8 D). Typical of EBS, suprabasal layers remained in-
tact, reflective of expression of K1 and K10, concomitant
with downregulation of K5 and K14 in these layers (Fuchs
and Green, 1980; Roop et al., 1987). However, in both se-
verely cytolyzed and in detached regions, the overall mor-
phology of the epidermis was distorted, suggesting that
significant perturbations had occurred in the biochemistry
of these cells, presumably beginning before the time at
which they exited the basal layer.
The phenotype of these mice was sufficiently severe that
they died within several days after birth unless given spe-
cial care. While we did not analyze internal complications
in detail, the mice also suffered from degeneration of the
tongue and oral epithelia, places where the K14 promoter
is known to be active. Taken together, the expression of
K18 seemed to restore some, but clearly not all, of the de-
fects caused by removal of K14 expression in mice.
Restoration of the 10-nm Filament Network
in Basal Cells of K181/K14 Null Back Skin, but Not 
Paw Skin
To evaluate the effects of K18 expression on cytoskeletal
architecture, we first examined the basal keratinocytes in
the paw and back skin of K18 transgenic mice on a wild-
type background. At the ultrastructural level, filament
bundles within K18 basal epidermal cells appeared indis-
tinguishable from those in wild-type basal epidermal cells,
and no signs of keratin clumps or other perturbations were
detected (Fig. 9 A). Desmosomes and hemidesmosomes
appeared normal, and both were surrounded by densely
staining keratin, as expected for the comparable wild-type
structures. Basal keratinocytes cultured from the skin of
K18 transgenic mice also displayed a seemingly normal
keratin network, which colabeled with antibodies against
K18, K5, and K14 (data not shown). Taken together, these
findings were in agreement with similar in vitro findings by
Lu and Lane (1990), who demonstrated that K18 is able to
integrate into an epidermal keratin network without per-
turbation. The result was also consistent with the normal
appearance of the K18 transgenic mice.
We next examined the cytoskeletal architecture of the
skin of K18 positive/K14 null mice. A number of the back
skin basal cells of these mice displayed seemingly normal
cytoskeletal networks, with bundles of cytoplasmic kera-
tin filaments connecting to hemidesmosomes and desmo-
somes (Fig. 9 B). This was in contrast to the back skin of
K14 null mice, but it was similar to that seen in the K16-14
rescue mice (Fig. 3). In these regions of the skin, no signs
of microblisters were detected, and the basal cells ap-
peared generally healthy.
Whereas the majority of back skin basal cells from K18
transgenic/K14 null mice appeared ultrastructurally nor-
mal, an occasional cell exhibited signs of degeneration
Figure 8. K18 expression does not rescue the blistered paw phe-
notype of K14 null mice. Neonatal back skins and paw skins from
K181/K141, K181/K142, and wild-type littermates were em-
bedded in Epon, sectioned (0.75 mm), and then stained with
Toluidine blue. Sections shown are from K18 transgenic skin on a
K14 null background. (A) back skin, showing no obvious abnor-
malities; (B) paw skin, depicting early signs of basal cell degener-
ation (arrowheads); (C) paw skin showing clear signs of basal cell
cytolysis (arrows); (D) paw skin showing blister resulting from
completely degenerated basal epidermal layer. Double arrow,
blister;  arrowheads in D, fragments of basal cells left on the blis-
ter floor, indicative of basal cell rupturing. Bars: (A and B) 40
mm; (C and D) 20 mm.The Journal of Cell Biology, Volume 143, 1998 494
(Fig. 9 C, asterisk). Some vacuolization was also seen, a
feature also frequently found in Weber-Cockayne EBS,
the mildest form of human EBS (for review see Anton-
Lamprecht, 1994; Fuchs and Cleveland, 1998). A few bun-
dles of keratin filaments were still detected in these cells,
but regions of the cytoplasm were devoid of such filaments
(Fig. 9 C, large arrowhead). In a few regions of the cyto-
plasm of these cells, a mixture of filaments and aggregates
of keratin-like material were detected (Fig. 9 C9). Clumps
of keratin were not seen in the K14 null skin (Lloyd et al.,
1995), but are characteristic of dominant-negative acting
keratin mutants in mice and in humans (Vassar et al., 1991;
Anton-Lamprecht, 1994).
Abnormalities in keratin networks were significantly
more prominent in the basal cells of the paw skin of K18
positive/K14 null mouse skin, i.e., in regions where overt
skin blistering was also readily detected (Fig. 9 D). In
many of these cells, large areas of cytoplasm were devoid
of keratin, while other areas were densely packed with
clumps or aggregates of keratin-like material. These
clumps often associated with desmosomes (Fig. 9 D, inset),
and at higher magnification, they appeared as aggregates
of short filamentous-like structures (D9). In Fig. 9 D0, de-
picting the junction between a basal cell (BC) and a
spinous cell (SP), note that the spinous cells contained an
array of keratin filaments; this is again consistent with the
switch to expression of K1 and K10 in terminally differen-
tiating layers.
Immunoelectron microscopy confirmed that the clumps
of material in the basal cells were keratin, and that they la-
Figure 9. Ultrastructure of basal
cells from the back skins and
paw skins of K18 transgenic
mice bred on either a wild-type
or a K14 null background. Skins
of 1–2-d-old K18 transgenic
mice on either a wild-type or
K14 null background were pro-
cessed for electron microscopy
as described in the Materials
and Methods. (A) basal cells
from K18 transgenic/K14 wild-
type back skin, depicting normal
keratin filament bundles (kf)
and desmosomes (de). Paw skin
showed similar morphology. (B–
D) basal cells from K18 trans-
genic/K14 null back skin (B and
C) or paw skin (D). The major-
ity of basal cells in back skin dis-
played normal morphology and
keratin filament bundles, similar
to that seen in B. An occasional
basal cell from back skin exhib-
ited signs of cytolysis (asterisks
and  small arrowheads), with
some regions of the cytoplasm
devoid of keratin filaments
(large arrowhead in C) and
other regions showing some
small aggregates or clumps of
keratin (C9, kc). Many cells from
paw skin displayed prominent
clumping of keratin both in the
cytoplasm and associated with
the desmosomes (D and inset to
D, respectively). D9 and D0
show higher magnification to vi-
sualize these clumps of keratin
in more detail. Note that spinous
cells (SP) contained a largely
normal keratin network, reflec-
tive of the induction of K1 and
K10 in these layers. BL, basal
lamina;  mi, mitochondria; hd,
hemidesmosome;  Nu, nucleus; BC,
basal cell. Bar in A: (A) 0.4 mm;
(B, C9, D9, D0) 0.3 mm; (C) 0.9 mm;
(D) 0.8 mm; (inset to D) 0.1 mm.Hutton et al. K14/K18 Replacement in Knockout Mice 495
beled not only with antibodies against K18, but also with
antibodies against K5 (Fig. 10). Since these clumps were
not detected in K14 null mice, we conclude that the clumps
represent a new structure produced from a combination of
K18 and K5, or possibly other cytoplasmic proteins.
The Keratin Network in K18 Replacement Skin Cannot 
Withstand Mechanical Trauma
A priori, the detection of keratin clumps in the K18 re-
placement skin could imply that the assembly process is
defective, or that there is an excess of K5 relative to K18.
Either case might result in the accumulation of partially
polymerized keratin material. Alternatively, it could be an
indication that the resulting keratin network formed by
K18/K5 filaments is unstable, and collapses partially upon
mechanical stress. To distinguish between these possibili-
ties, we conducted an experiment to see how the basal epi-
dermal layer would perform under mechanical stress.
Four 2-d-old K14 null/K181 replacement mice and two
control littermates were subjected to mild rubbing of the
back skin, which was then processed for ultrastructural
analysis immediately thereafer (within 10 min). In each
case, only the left side of the middle lower back was
rubbed (12 times with a cotton-tipped applicator); the
right side of each mouse was not rubbed, and was used as a
control for each mouse.
Some basal epidermal cells of rubbed, K18 transgenic/
K14 null skin survived the rubbing, as judged by the pres-
ence of a seemingly normal keratin filament network and
generally healthy cytoplasm (Fig. 11 A). However, a num-
ber of cells displayed clumps or aggregates of keratin ma-
terial (Fig. 11 B). The aberrancies in keratin networks
were similar, but more extensive than those seen in occa-
sional back skin cells of unrubbed K18 replacement skin
and in many paw skin cells. As expected, we did not ob-
serve signs of cell cytolysis, a delayed response which in
human EBS occurs subsequent to alterations in cytoskele-
tal architecture (for review see Anton-Lamprecht, 1994).
In contrast to the basal cells from rubbed back skin of
the K181/K14 null mice, cells from similarly rubbed back
skin of control mice appeared uniformly healthy, with lit-
tle or no perturbations in overall morphology (Fig. 11 C).
Taken together, our findings suggest that the perturba-
tions detected in basal cells of K18 replacement skin are
accentuated by mechanical stress.
When Combined in the Presence of 6 M
Urea, K5 and K18 Associate in a 1:1 Ratio to Form a 
Complex That Then Assembles into Filaments 
Efficiently In Vitro
Our in vivo studies suggested that K5 and K18 can assem-
ble into keratin filaments. To test this hypothesis in vitro
and analyze this interaction in more detail, we first demon-
strated that K5 and K18 can form stable heterotypic com-
plexes under 6 M urea buffer conditions. We showed this
by anion exchange chromatography (not shown) and by
chemical cross-linking (Fig. 12 A). Cross-linking using BS3
showed that the major K5-K18 and K5-K14 species
formed under these conditions was a 240-kD product, with
small amounts of an z130-kD product (Fig. 12 A). As
shown previously (Coulombe and Fuchs, 1990), these spe-
cies correspond to covalently cross-linked heterotetramers
and heterodimers of keratins, respectively. When the urea
concentration was raised to 8 M under otherwise identical
conditions, the K5-K18 tetramers were destabilized to a
greater extent than K5-K14 ones (data not shown). Taken
together, these data show that K18 can readily form het-
erotetramers in combination with K5, although these are
slightly less stable than those formed from K5-K14.
When dialyzed under standard epidermal keratin as-
sembly buffer, K5-K18 heterotypic complexes polymer-
ized efficiently (90%) into 10-nm filaments that are similar
to those formed by K5-K14 (.95% efficiency) (Fig. 12,
Figure 10. Keratin clumps in K18 transgenic/K14 null basal cells
contain a mixture of K5 and K18. Paw skin from K18 transgenic/
K14 null animals was embedded in Lowicryl and subjected to 30-
nm gold labeling with antibodies against either K18 (A) or K5
(B) as described previously (Coulombe et al., 1989). de, desmo-
some; hd, hemidesmosome; kc, keratin clumps. Bar, 0.2 mm.The Journal of Cell Biology, Volume 143, 1998 496
compare B and C, respectively). Under in vitro assembly
conditions, it was not possible to distinguish reliably those
filaments formed from K5-K18 versus those formed from
K5-K14. Taken together with our in vivo data, these re-
sults provide further evidence that K18 is an effective part-
ner for K5, and that the failure of K18 to fully rescue the
EBS phenotype resides in the physical properties of the
filament network, rather than in K18’s ability to assemble
into a 10-nm filament network.
Discussion
Previously, we showed that K14 null animals exhibit blis-
tering upon physical stress, a feature that is due to me-
chanically induced degeneration in their epidermal basal
layer (Lloyd et al., 1995). This study provided compelling
evidence that the epidermal keratin network functions to
impart mechanical integrity to keratinocytes. Stress-induced
blistering of the basal epidermal layer is the hallmark of
EBS in humans, and it is known that genetic alterations in
the K5 and K14 network are responsible for this disorder
(Bonifas et al., 1991; Coulombe et al., 1991; Lane et al.,
1992). Although human EBS typically involves keratin fil-
ament–disrupting mutations in the K5 or K14 genes and is
inherited in an autosomal dominant fashion, rare cases of
recessive homozygous mutations have been described that
show a dramatic reduction in keratin filaments within the
basal layer of the skin (Chan et al., 1994; Rugg et al.,
1994). True K14 null mutations have been engineered in
mice, and these mice exhibit an EBS phenotype (Lloyd et
al., 1995).
Our previous studies on K14 null mice demonstrated
that in the absence of K14, there is no dramatic upregula-
tion of other type I keratins to provide compensation for
the loss of this keratin (Lloyd et al., 1995). In the absence
of a partner, the basal type II keratin K5 was still present,
but unable to form a keratin filament network. This was
consistent with predictions made from in vitro filament as-
sembly studies arguing that K5 and K14 form obligatory
heterodimers (Coulombe and Fuchs, 1990; see also
Hatzfeld and Weber, 1990; Steinert, 1990). In the absence
of K14, there is a very sparse keratin filament network
made in the basal layer, resulting from the presence of
very low levels of K15 in postnatal mouse skin (Lloyd et
al., 1995). However, this sparse network was not able to
sustain the mechanical stress normally handled by the
more robust bundles of K5-K14 filaments.
To test the possibility that a non-epidermal type I kera-
tin might be able to restore mechanical stability to the
basal epidermal keratin network, we chose K18 as our re-
placement for K14. Indeed, K8/K18 are the major keratins
of simple epithelial tissues just as K5 and K14 are the key
keratins of stratified epithelia (Moll et al., 1982). More-
over, in contrast to most keratins, these two keratin pairs
are often expressed in the absence of any other keratins,
establishing that in their respective tissue, they can on
their own form extensive keratin networks. Since the di-
viding populations of simple epithelia and epidermis are
so dramatically different in their morphology and in their
physical properties, we felt that this replacement would
provide a major test of whether there are fundamental dif-
ferences in the two respective keratin networks.
On a wild-type background, our K18 transgenic mice
displayed no overt phenotype and showed no loss of via-
bility with age. This was also true for K18 transgenic mice
on a heterozygous K14 background, where the levels of
K18 approached those of K14. We have cultured the trans-
genic basal epidermal cells, and they too behaved nor-
mally and exhibited a normal keratin network that labeled
with antibodies against endogenous basal keratins or K18
(Hutton, E., and E. Fuchs, unpublished observations).
Thus, both in vivo and in vitro, K18 seemed to integrate
into the endogenous K5-K14 keratin network without any
noticeable perturbations. Moreover, in vivo, a basal kera-
tin network composed of K5, K14, and K18 seemed able to
withstand the natural environmental stresses in a fashion
analogous to the K14-K5 network. This was the case irre-
spective of whether the mice contained one or two of their
K14 alleles.
Figure 11. In K18 transgenic/K14 null basal cells, the morpholog-
ical deviations from a wild-type keratin network become more
pronounced upon mechanical stress. Two separate litters of neo-
natal mice were used for these studies. For each litter, two K18
transgenic/K14 null and one wild-type littermates were subjected
to lateral rubbing of the skin on one side of the back, and no rub-
bing on the other side. After the rubbing experiment, skins from
each side of the back of each animal were processed for conven-
tional electron microscopy. Skin samples were analyzed for alter-
ations in the morphology of the basal keratin network. Many of
the basal cells maintained a proper keratin network (A). Approx-
imately 20% of the basal cells of K18 transgenic/K14 null back
skin showed signs of keratin clumping on the rubbed side (B).
The majority of the basal cells from unrubbed back skin dis-
played keratin filaments typical of wild-type skin (not shown).
Wild-type skin showed abundant keratin filament bundles and no
keratin clumps irrespective of whether the skin was rubbed or not
(C). Bar in A: (A and B) 0.4 mm; (C) 0.3 mm.Hutton et al. K14/K18 Replacement in Knockout Mice 497
Overall, the behavior of the transgenic K18 mice
seemed to be markedly different from that of transgenic
K16 mice generated using the same K14 basal epidermal
promoter: in that case, expression of K16 at .60% the lev-
els of endogenous K14 resulted in skin that was hyper-
keratotic, scaly and devoid of fur (Paladini and Coulombe,
1998). It could be that the differences in K18 versus K16
transgenic phenotypes stem from the higher level of ex-
pression (or increased stability) of K16 than K18. How-
ever, it seems more likely that these differences stem from
inherent differences in keratins, particularly since the K16-
14 hybrid protein behaved normally when expressed in
mice at comparable levels to K16 (Paladini and Coulombe,
1998). Taken together, even at the transgenic level, there
appear to be differences in the behavior of type I keratins
expressed under the control of a basal epidermal keratin
promoter.
Even on a K14 null background, transgenic K18 still
functioned quite well in back skin, where it coassembled
with K5 to form a network of keratin filaments in the basal
epidermal layer. That K5 and K18 can form bona fide 10-
nm filaments in the absence of K14 was also confirmed
from our in vitro studies. These in vitro–assembled K18/
K5 filaments were similar in structure, appearance, and
concentration to the epidermal counterparts. Taken to-
gether, these findings indicate that K18 is a suitable part-
ner for K5 in keratin filament assembly.
The keratin filaments formed by K5 and K18 in vivo as-
sociated both with hemidesmosomes and with desmo-
somes in the basal epidermal layer. While the molecular
details of the interaction between hemidesmosomes and
IFs have not been fully elucidated, in vitro studies suggest
that the interaction between desmosomes and keratin fila-
ments occurs through binding of the desmoplakin tail seg-
ment to the head domain of type II epidermal keratins
(Kouklis et al., 1994; Kowalczyk et al., 1997). In the K18
positive/K14 null mice, the K5 head domain is presumably
still available to associate with desmoplakin, and this could
explain why we did not observe any perturbation in kera-
tin filament attachments to cell junctions. Interestingly,
the interaction between K8 and desmoplakin seems to be
much weaker than that with K5 (Kouklis et al., 1994),
leading us to wonder whether desmosomal interactions
might have been compromised if we had exchanged the
type II rather than the type I keratins. The answer to this
question must await further replacement studies.
Despite the ability of K5 and K18 to assemble into fila-
ments and to make a keratin filament network in basal
epidermal cells, K18 did not fully compensate for the loss
of K14, even at the highest levels that we were able to
achieve in the present study. These mice still died within
several days after birth, presumably because of both inter-
nal and external complications (see Lloyd et al., 1995 for a
description of internal abnormalities in the K14 null mice).
Within the skin, the severity in blistering and perturba-
tions in the keratin network seemed to correlate with de-
gree of mechanical stress, as judged by the fact that the pa-
thology was most prominent in paw skin, a region of
natural stress, and it was exacerbated in response to physi-
cal rubbing of back skin. Taken together, these observa-
tions suggest a model whereby the K18/K5 network as-
sembles, but is unable to withstand mechanical stress,
leading to a collapse of the network and skin blistering. In
the future, cytoskeletal tension measurements might be
used to address this hypothesis directly.
The current limitations of keratinocyte promoter activ-
ity and/or K18 turnover rates precluded our examining the
consequences of expressing higher levels of K18, and thus
we cannot say whether comparable to wild-type K14 levels
of K18 might better compensate for the loss of K14 in our
mice. This said, mice and humans harboring only a single
functional K14 allele behave normally (Chan et al., 1994;
Rugg et al., 1994; Lloyd et al., 1995), and in the present
study, K14 null mice expressing the K16-14 transgene sur-
vived to adulthood and showed no overt signs of skin blis-
tering. Thus, while gross differences in filament density
can certainly influence basal epidermal cell survival (Chan
et al., 1994; Rugg et al., 1994; Lloyd et al., 1995), more sub-
tle differences in filament density may be less important
than the particular keratins involved in conferring me-
chanical integrity to a tissue.
Our data lend support to the notion that the specific
keratins composing an IF network in vivo are central to
cytoskeletal architecture and design in cells (for recent re-
lated papers on this subject, see Paladini et al., 1996; Pala-
dini and Coulombe, 1998). Before our study, a number of
differences had already been recognized between K8/K18
and K5/K14. For instance, the physical properties of K8/
Figure 12. Assembly of K18 and K5 into 10-nm
keratin filaments. (A and B) Pure preparations of
K5, K18, and K14 in 6 M urea buffers were ob-
tained by FPLC chromatography, as described by
Coulombe and Fuchs (1990). Keratin-rich frac-
tions were pooled, and the protein concentration
measured using an assay kit (Bio-Rad Laborato-
ries). Equimolar mixtures of K5/K18 or K5/K14
were subjected to anion-exchange chromatogra-
phy to purify the heteromeric complexes. Com-
plexes were confirmed by chemical cross-linking
with BS3 as described previously (Wawersik et
al., 1997). Samples of unlinked (2) and cross-
linked (1) proteins were subjected to SDS-
PAGE, and the gel was stained with Coomassie
blue to visualize the protein. D, dimer; T, tetramer. (B and C) Complexes of either K5/K18 (B) or K5/K14 (C) were subjected to in
vitro filament assembly as described in Materials and Methods. Filaments were visualized under a Philips CM10 electron micro-
scope. Bar, 100 nm.The Journal of Cell Biology, Volume 143, 1998 498
K18 heterodimers and filaments assembled from them dif-
fer markedly from K5/K14 heterodimers and their corre-
sponding filaments (Franke et al., 1983; Hatzfeld and
Franke, 1985; Coulombe and Fuchs, 1990; Hatzfeld and
Weber, 1990; Hoffmann and Franke, 1997). Moreover, in
vivo, K8/K18 networks can reorganize during mitosis in
some cells, whereas K5/K14 networks do not, suggesting
the possibility that K8/K18 networks may be more dy-
namic than K5/K14 networks (Franke et al., 1983). Dra-
matic sequence and size differences in the head and tail
segments and in the posttranslational modifications of ker-
atins are likely to account for at least a part of these dra-
matic variations in keratin networks (Lu and Lane, 1990;
Liao et al., 1995 and references therein; for review see
Fuchs and Weber, 1994). It is tempting to speculate that
K18 cannot fully compensate for K14 because it creates a
more dynamic keratin network that is not entirely compat-
ible with the structural requirements imposed upon a tis-
sue like the epidermis.
The seemingly less stable aspects of the K5/K18 network
could also have arisen from genetically forcing an undesir-
able partner upon K5. That keratins have distinct prefer-
ences for their partners has been recently inferred from
K18 knockout studies, where when left without its normal
partner, K8 can successfully compete for K19, normally
the partner of K7 (Magin et al., 1998). To assess whether
K8/K18 can replace K5/K14 must await further replace-
ment studies.
In summary, our study suggests that the multiplicity of
keratin sequences is not simply an evolutionary quirk, but
that these proteins have diverged to perform specific func-
tions in higher eukaryotic epithelia. Whereas keratin net-
works are a universal feature of epithelia, their density,
composition, and organization vary dramatically and seem
to be tailored to the varied shapes and structural require-
ments of individual epithelial cells.
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